Original language | Italian |
---|---|
Pages (from-to) | e206-e217 |
Journal | The Lancet Oncology |
Volume | 18 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2017 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. / Cavo, M.; Terpos, E.; Nanni, C.; Moreau, P.; Lentzsch, S.; Zweegman, S.; Hillengass, J.; Engelhardt, M.; Usmani, S.Z.; Vesole, D.H.; San-Miguel, J.; Kumar, S.K.; Richardson, P.G.; Mikhael, J.R.; da Costa, F.L.; Dimopoulos, M.-A.; Zingaretti, C.; Abildgaard, N.; Goldschmidt, H.; Orlowski, R.Z.; Chng, W.J.; Einsele, H.; Lonial, S.; Barlogie, B.; Anderson, K.C.; Rajkumar, S.V.; Durie, B.G.M.; Zamagni, E.
In: The Lancet Oncology, Vol. 18, No. 4, 2017, p. e206-e217.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
AU - Cavo, M.
AU - Terpos, E.
AU - Nanni, C.
AU - Moreau, P.
AU - Lentzsch, S.
AU - Zweegman, S.
AU - Hillengass, J.
AU - Engelhardt, M.
AU - Usmani, S.Z.
AU - Vesole, D.H.
AU - San-Miguel, J.
AU - Kumar, S.K.
AU - Richardson, P.G.
AU - Mikhael, J.R.
AU - da Costa, F.L.
AU - Dimopoulos, M.-A.
AU - Zingaretti, C.
AU - Abildgaard, N.
AU - Goldschmidt, H.
AU - Orlowski, R.Z.
AU - Chng, W.J.
AU - Einsele, H.
AU - Lonial, S.
AU - Barlogie, B.
AU - Anderson, K.C.
AU - Rajkumar, S.V.
AU - Durie, B.G.M.
AU - Zamagni, E.
N1 - Cited By :14 Export Date: 22 February 2018
PY - 2017
Y1 - 2017
U2 - 10.1016/S1470-2045(17)30189-4
DO - 10.1016/S1470-2045(17)30189-4
M3 - Articolo
VL - 18
SP - e206-e217
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 4
ER -